Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jan 13, 2023 (4 years ago)

Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Short Fill

Cause type: Failed specification

A physical or chemical test other than potency, dissolution, impurity or stability failed - pH, viscosity, appearance, tablet integrity, fill volume. A product outside its own specification may not perform as designed, even if the active ingredient is present. All failed specification recalls.

What was recalled

Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator (racephedrine, USP 11.25), 30x0.5 mL Sterile Vials each in a foil pouch, NDC 0487-2784-01 UPC 3 04872 78401 4

Affected NDC 0487-2784-01

Compare with the code on your package — it is the most precise check available.

Drug: Epinephrine

Recalling firm
Nephron Sc Inc
NDC code
0487-2784-01
Origin
SC, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0175-2023 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Epinephrine recalls

See all
Class I · High risk

Epinephrine Injection

Presence of Particulate Matter and Lack of Assurance of Sterility. Particulate matter identified as nylon, cellulosic, acrylic, polyethylene and glass and broken and leaking vials.

Ongoing Sterility / contamination American Regent, Inc. NDC 0517-3030-01 D-0865-2026
Class II · Moderate risk

Maximum

Stability Data Does Not Support Expiry Date.

Ongoing Stability / shelf life HTO Nevada Inc. dba Kirkman D-0387-2026

Other recalls by Nephron Sc Inc

All 2023 recalls
Class II · Moderate risk

Sterile Water for Injection

CGMP Deviations: potential for trace amounts of product carryover.

Terminated cGMP deviation Nephron Sc Inc NDC 0487-6105-01 D-0178-2023